- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 175.43M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.98B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.77B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.03B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.84B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.03B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.83B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $42.68M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $49.59M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 157.92M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $2.7M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $74.25M |
| Capex | Q1 2025 · Mar 31, 2024 | $292K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$240.89M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.89B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.8B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.57 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.57 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | $90.96M |